Treatment of disruptive mood dysregulation disorder with autism spectrum disorder and attention-deficit/hyperactivity disorder

Mental Health Clinician · Published 2026-02-01 · DOI 10.9740/mhc.2026.02.001

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.9740/mhc.2026.02.001

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management · Mental Health Clinician · 2025 · Same journal
• Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation · Mental Health Clinician · 2026 · Same journal
• Pharmacological management of binge eating disorder · Mental Health Clinician · 2025 · Same journal
• Benzodiazepine use in schizophrenia: A review of the literature · Mental Health Clinician · 2025 · Same journal
• Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report · Mental Health Clinician · 2025 · Same journal
• Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report · Mental Health Clinician · 2025 · Same journal
• Management of antidepressant-induced bruxism · Mental Health Clinician · 2025 · Same journal
• Involuntary medication treatment of schizophrenia in the inpatient setting · Mental Health Clinician · 2024 · Same journal
• Exacerbation of neuropsychiatric symptoms in an adult male with influenza A virus treated with oseltamivir · Mental Health Clinician · 2024 · Same journal
• Appropriate use of single-dose injectable aripiprazole lauroxil in the treatment of schizophrenia · Mental Health Clinician · 2024 · Same journal